C92.4 Acute promyelocytic leukaemia [PML] - analogs
| Description «C92.4 Acute promyelocytic leukaemia [PML]» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 30% Compare C94.2 Acute megakaryoblastic leukaemia
- 30% Compare C95.0 Acute leukaemia of unspecified cell type
- 30% Compare C95 Leukaemia of unspecified cell type
- 30% Compare C92.5 Acute myelomonocytic leukaemia
- 30% Compare C94 Other leukaemias of specified cell type
- 20% Compare C92.0 Acute myeloblastic leukaemia [AML]
- 20% Compare C91.9 Lymphoid leukaemia, unspecified
- 20% Compare C91 Lymphoid leukaemia
- 18% Compare C91.0 Acute lymphoblastic leukaemia [ALL]
- 18% Compare C95.1 Chronic leukaemia of unspecified cell type
- 15% Compare C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive
- 13% Compare C93 Monocytic leukaemia
- 13% Compare C92 Myeloid leukaemia
- 13% Compare C92.7 Other myeloid leukaemia
- 13% Compare C91.5 Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
- 13% Compare C94.7 Other specified leukaemias
- 13% Compare C90.1 Plasma cell leukaemia
- 13% Compare C95.9 Leukaemia, unspecified
- 13% Compare C92.2 Atypical chronic myeloid leukaemia, BCR/ABL-negative
- 12% Compare C91.1 Chronic lymphocytic leukaemia of B-cell type
- 10% Compare D13.4 Benign neoplasm, liver
- 10% Compare C34.1 Malignant neoplasm, upper lobe, bronchus or lung
- 10% Compare C34.9 Malignant neoplasm, bronchus or lung, unspecified
- 10% Compare C22.0 Malignant neoplasm, liver cell carcinoma
- 10% Compare E88.3 Tumour lysis syndrome
- 10% Compare C67.9 Malignant neoplasm, bladder, unspecified
- 10% Compare C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
- 10% Compare C41.4 Malignant neoplasm, pelvic bones, sacrum and coccyx
- 10% Compare C54.1 Malignant neoplasm, endometrium
- 10% Compare D29.0 Benign neoplasm, penis
- 10% Compare C67 Malignant neoplasm of bladder
- 10% Compare C51.9 Malignant neoplasm, vulva, unspecified
- 10% Compare C22.9 Malignant neoplasm, liver, unspecified
- 10% Compare C77 Secondary and unspecified malignant neoplasm of lymph nodes
- 10% Compare C38.3 Malignant neoplasm, mediastinum, part unspecified
- 10% Compare C76-C80 Malignant neoplasms of inaccurately designated, secondary and unspecified localizations
- 10% Compare C15.5 Malignant neoplasm, lower third of oesophagus
- 10% Compare C51 Malignant neoplasm of vulva
- 10% Compare C40.9 Malignant neoplasm, bone and articular cartilage of limb, unspecified
- 10% Compare C32 Malignant neoplasm of larynx
- 10% Compare C40 Malignant neoplasm of bone and articular cartilage of limbs
- 10% Compare C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
- 10% Compare C22.7 Malignant neoplasm, other specified carcinomas of liver
- 10% Compare C38.1 Malignant neoplasm, anterior mediastinum
- 10% Compare C30.0 Malignant neoplasm, nasal cavity
- 10% Compare C74.9 Malignant neoplasm, adrenal gland, unspecified
- 10% Compare C71.0 Malignant neoplasm, cerebrum, except lobes and ventricles
- 10% Compare C40-C41 Malignant neoplasms of bones and articular cartilage
- 10% Compare C49.4 Malignant neoplasm, connective and soft tissue of abdomen
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.